Key facts
- Notable investors include K5 Global, Rubik Ventures (New York), New Form Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Acadia (New York)
- ·The full record, as it builds
Funding rounds
No funding rounds for Acadia (New York) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Acadia (New York)
Developer of an artificial intelligence-native platform designed to optimize administrative workflows in ophthalmology practices. The company platform offers virtual workers that integrate with existing systems to automate tasks such as eligibility checks, prior authorizations, surgical estimates, charge coding, and claims management, enabling ophthalmologists to streamline operations and improve practice efficiency.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Website
- acadia.xyz/
- Ownership
- Privately Held (backing)
Acadia (New York) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Acadia (New York) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Acadia (New York) in its N-PORT filings yet. We sweep new filings monthly.